Logo Image

Podcasts

Recent Episodes

The Patients Missing From Breast Cancer Data
The Patients Missing From Breast Cancer Data
Beyond the Scan: Predicting Immunotherapy Response With ctDNA in NSCLC
Beyond the Scan: Predicting Immunotherapy Response With ctDNA in NSCLC
Dr Bazhenova on the Updated FDA Label for Taletrectinib in ROS1+ NSCLC
Dr Bazhenova on the Updated FDA Label for Taletrectinib in ROS1+ NSCLC
Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial Access
Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial Access
Dr Jhaveri on the FDA Approval of Imlunestrant Plus Abemaciclib for ESR1-Mutated Breast Cancer
Dr Jhaveri on the FDA Approval of Imlunestrant Plus Abemaciclib for ESR1-Mutated Breast Cancer
Dr Herzberg on the Expanding Toolkit in KRAS-Mutant Non–Small Cell Lung Cancer
Dr Herzberg on the Expanding Toolkit in KRAS-Mutant Non–Small Cell Lung Cancer
ASTRO 2026 Preview: Dr Raj Singh on De-Escalation, Brain Metastases, and What's Next in Radiation Oncology
ASTRO 2026 Preview: Dr Raj Singh on De-Escalation, Brain Metastases, and What's Next in Radiation Oncology
Bringing CAR T and Bispecifics to the Community
Bringing CAR T and Bispecifics to the Community
Rethinking HER2: A Pan-Cancer Look at IHC, ERBB2, and Tumor-Agnostic Testing
Rethinking HER2: A Pan-Cancer Look at IHC, ERBB2, and Tumor-Agnostic Testing
Radiation Oncology's Financial Squeeze With Dr Ryan Funk
Radiation Oncology's Financial Squeeze With Dr Ryan Funk

All series

Oncology Brothers

Oncology Brothers

All Podcasts